ARTV insiders were on both sides of the trade this year. Buys came to roughly $109.2 million (11 buyers), sales to $2.7 million (five sellers).
Biggest single buyer: RA Capital Nexus Fund III, L.P., Director, with roughly $75 million.
72 investment managers listed ARTV in their latest 13F filings (Q2 2026); more funds bought than sold. Quarter by quarter: 2 quarters in a row of net buying by insiders. Insiders bought in 2 of the last 7 full quarters. This quarter so far: net selling.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Aslan Fred | CEO | Sell | 23,463 | $7.20 | $169K | SEC |
| Oct 6, 2026 | Aslan Fred | CEO | Sell | 61,696 | $6.84 | $422K | SEC |
| Oct 6, 2026 | Banerjee Subhashis | Executive Officer | Sell | 1,099 | $6.84 | $8K | SEC |
| Oct 6, 2026 | Horan Christopher | Executive Officer | Sell | 10,340 | $6.84 | $71K | SEC |
| Oct 6, 2026 | Bush Jennifer | COO | Sell | 8,370 | $6.84 | $57K | SEC |
| Sep 9, 2026 | Aslan Fred | CEO | Sell | 23,429 | $10.92 | $256K | SEC |
| Sep 4, 2026 | Horan Christopher | Executive Officer | Sell | 10,366 | $11.16 | $116K | SEC |
| Sep 4, 2026 | Bush Jennifer | COO | Sell | 8,391 | $11.16 | $94K | SEC |
| Sep 4, 2026 | Banerjee Subhashis | Executive Officer | Sell | 1,100 | $11.16 | $12K | SEC |
| Sep 4, 2026 | Aslan Fred | CEO | Sell | 61,888 | $11.16 | $691K | SEC |
| Aug 31, 2026 | Banerjee Subhashis | Executive Officer | Sell | 8,222 | $12.01 | $99K | SEC |
| Aug 19, 2026 | Banerjee Subhashis | Executive Officer | Sell | 429 | $12.00 | $5K | SEC |
| Jul 31, 2026 | RA Capital Healthcare Fund LP | Director | Buy | 24,944 | $9.93 | $248K | SEC |
| Jul 31, 2026 | RA Capital Healthcare Fund LP | Director | Buy | 20,824 | $9.99 | $208K | SEC |
| Jul 28, 2026 | RA Capital Nexus Fund III, L.P. | Director | Buy | 41,319 | $9.99 | $413K | SEC |
In the last 12 months Artiva Biotherapeutics, Inc. insiders made open-market purchases worth about $109.2 million and sales worth about $2.7 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in ARTV was filed on 2026-10-07.
72 investment managers reported holding ARTV in SEC Form 13F filings for Q2 2026.
No congressional trades in ARTV were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).